State of the art in therapy for non-small cell lung cancer.
about
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosisDown-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-MetHsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway.MiR-338-3p inhibits the growth and invasion of non-small cell lung cancer cells by targeting IRS2.Current paradigms for metastatic spinal disease: an evidence-based review.Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation.MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.Long non-coding RNA NEAT1 regulates E2F3 expression by competitively binding to miR-377 in non-small cell lung cancer.Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.miR-769-5p suppressed cell proliferation, migration and invasion by targeting TGFBR1 in non-small cell lung carcinoma.MicroRNA-20a promotes proliferation and invasion by directly targeting early growth response 2 in non-small cell lung carcinoma.Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo.Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting
P2860
Q24655144-5E2054B1-1739-49E6-8951-B5011D4E3231Q28283742-075B8C57-A104-4674-BF5F-F8C45AA32DFAQ36413232-E418A870-89BF-4313-A9A3-43AFE8B5757BQ36545471-51C962F2-DF60-4AC4-AD48-3FB038BC5286Q36946799-7C758C6C-F00F-4FCB-9E41-886071A4219AQ37225326-F3CD103C-AEC7-4F30-9FF6-7EA4CC4D7FC4Q37501595-335A373E-5961-4928-822D-B9E83CE0A27FQ37588369-863CE1EE-F9BA-490E-96D2-23582F48B838Q37596819-14AC6A7C-6A8C-4086-8881-E063B23A7259Q38154497-7C706BE0-FF6E-4EFA-B50B-17DDF51187C3Q38752068-944FB6B4-AA70-434B-AA47-907550E16151Q38807193-9CC14193-072F-4D0B-B8D1-46583AF2DFA8Q39367785-614A6225-320D-4779-9A53-86994B9A04A2Q47143921-90DE03AC-2C2C-45CE-AECC-792525D0F962Q48616480-84F8C570-8A88-4F61-A014-358657025186Q49183391-23CA7095-8E91-4D21-A014-20810CA071CBQ49184940-3E0ECCD1-0D1A-4625-B5D2-BA78E0CC0735Q49375967-1BE21015-4925-4641-9067-9C38658E4EA6Q52657239-59238AFB-5588-4CFD-AE55-0AB7CA57486CQ53346364-4CC90D3C-E5CF-43A6-B3DB-D6238584F964Q58725258-7D37DDE3-5729-4531-BA29-B2936AC93D90Q58765854-2960CC61-0CF7-4309-8D9C-FCBF70C5A7F4
P2860
State of the art in therapy for non-small cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
State of the art in therapy for non-small cell lung cancer.
@ast
State of the art in therapy for non-small cell lung cancer.
@en
type
label
State of the art in therapy for non-small cell lung cancer.
@ast
State of the art in therapy for non-small cell lung cancer.
@en
prefLabel
State of the art in therapy for non-small cell lung cancer.
@ast
State of the art in therapy for non-small cell lung cancer.
@en
P2860
P356
P1433
P1476
State of the art in therapy for non-small cell lung cancer.
@en
P2093
Alan B Sandler
Janessa J Laskin
P2860
P304
P356
10.1081/CNV-67172
P577
2005-01-01T00:00:00Z